Skip to content

Clinical trials

Phase 2 Heart Failure trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: United Kingdom Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20072
20103
20111
20121
20135
20142
20164
20174
20182
20191
20201
20224
20234
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated9
Recruiting4
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Bayer4
Cardurion Pharmaceuticals, Inc.3
Cytokinetics2
GlaxoSmithKline2
NHS Greater Glasgow and Clyde2
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Pfizer2
Stealth BioTherapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure45
Cardiovascular Diseases4
Heart Diseases4
Cardiomyopathies2
Acute Coronary Syndrome1
Alzheimer Disease1
Cardiomegaly1
Cardiomyopathy, Dilated1
Diabetes Mellitus1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.